Alignment Healthcare Inc (NAS:ALHC)
$ 14.84 -3.76 (-20.2%) Market Cap: 3.08 Bil Enterprise Value: 2.71 Bil PE Ratio: 78.11 PB Ratio: 11.59 GF Score: 79/100

Q2 2024 Alignment Healthcare Inc Earnings Call Transcript

Aug 01, 2024 / 09:30PM GMT
Release Date Price: $8.62 (-1.37%)

Key Points

Positve
  • Alignment Healthcare Inc (ALHC) reported a 56% year-over-year growth in health plan membership, reaching 175,100 members.
  • Total revenue for the second quarter was $681 million, representing a 47% year-over-year increase.
  • Adjusted gross profit was $77 million, achieving the high end of the company's guidance range.
  • The company maintained a consolidated Medical Benefit Ratio (MBR) of 88.7%, showing strong cost management.
  • ALHC's investments in member experience, clinical infrastructure, and data platform have resulted in superior MBR outcomes and scalability.
Negative
  • The company is experiencing heightened levels of supplemental benefit expenses, which are expected to continue into 2025.
  • Unit costs for inpatient and outpatient services have increased by 8% in 2024, higher than the typical 3-4% increase.
  • New members typically join at a higher MBR, which can impact overall profitability.
  • Despite strong growth, the company still faces challenges in managing the mix of new members and their onboarding into clinical programs.
  • The company has decided not to enter any new states in 2025, potentially limiting its geographic expansion opportunities.
Operator

Good afternoon, and welcome to alignment Healthcare's Second Quarter 2024 Earnings Conference Call and Webcast. All participants will be in a listen-only mode. After the speaker presentation, there will be a question and answer session to ask a question. During the session, you will need to press star one one on your telephone. You will then hear an automated message advising that your hand has been raised. To withdraw your question, please press star one. Once again, please be advised that today's conference is being recorded. Leading today's call are John Kehoe, Founder and CEO, and Thomas Freeman, Chief Financial Officer.

Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are subject to various risks and uncertainties and reflect our current expectations based on our beliefs, assumptions and information currently available to us. Descriptions of some of the factors that could cause actual results to differ materially from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot